biowa,
Here's an updated "failed-to-deliver" list:
AQLA Aquila Biopharmaceuticals, Inc.
ARIA ARIAD Pharmaceuticals, Inc. - Common Stock
CLTR Coulter Pharmaceutical, Inc. - Common Stock
GLIA Gliatech Inc. - Common Stock
SCLN SciClone Pharmaceuticals, Inc. - Common Stock
SHPGY Shire Pharmaceuticals Group, plc - American Depository Shares
SUPG SuperGen, Inc. - Common Stock
ZONA Zonagen, Inc. - Common Stock
We've certainly had some excitement from the previous list, in particular from GLIA and AQLA. Still have no idea why AQLA finds itself on this list.
SHPGY and SUPG are the new entrants. I assume SHPGY is merger-related.
I still own SUPG, although I lightened up some. Fair amount of hype, so I can see a short being interested. Again a pretty dangerous short though, betting against them coming through in their pancreatic trial.
Peter |
